Funding Received
$32 Million in 2 Rounds from 1 Investor
Most Recent Funding
$20 Million Series D on June 5, 2008
Founded:
2004
Headquarters:
South San Francisco, CA
Description:
CoMentis is a biotech company engaged in the research and development of small molecule drugs to treat neurovascular diseases.
Categories:
Biotechnology
Website:
http://www.comentis.com

Detailed Description

Update

CoMentis is a biotech company focused on the research and development of small molecule drugs to treat neurovascular diseases such as Alzheimer's disease (AD), age-related macular degeneration (AMD) and other cognitive disorders. Originally founded in 2004 as Athenagen, Inc., the company was re-named CoMentis following its August 2006 merger with Zapaq, Inc., which created a leading neurovascular disease franchise.

Past Team (2)

Update

Funding Rounds (2) - $20M

Update

Board Members and Advisors (1)

Update

Investors (1)

Update
  • 9d43a1cd1deb00ba3053ab383419f0e3

    Wellington Partners

    Wellington Partners is a venture capital firm that invests in technology and life sciences...

Offices/Locations (1)

Update
  • Corporate Headquarters

    280 Utah Avenue, Suite 275

    South San Francisco, CA 94080

    USA

Images (1)

Update
  • 0607270fa6df79a2cb56b1b14d583e7b